Single Dose Enteral Tranexamic Acid in Critically Ill Patients

Stopped early · Phase 2

Conditions studied: Shock, Sepsis, Hypotension, Critical Illness

In brief

The premise of this study is that enteral tranexamic acid will help to maintain small bowel integrity, which is often compromised by critical illness due to inadequate cardiovascular perfusion (i.e., shock), and that maintenance of small bowel integrity will decrease morbidity in critically ill patients.

Key facts

Study ID
NCT01683747
Run by
San Diego Veterans Healthcare System
People needed
4
Starts
2012-06-01
Expected to finish
2014-11-01
Last updated by the study team
2015-11-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.